Literature DB >> 12525919

Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals.

F Luzzaro1, E F Viganò, D Fossati, A Grossi, A Sala, C Sturla, M Saudelli, A Toniolo.   

Abstract

The epidemiology of bacterial pathogens causing bloodstream infection was studied in 16 hospitals in Lombardy (northern Italy) over a 2-year period (1999 and 2000). Overall, 2924 microorganisms causing significant bacteremia were collected. The most frequent isolates were Escherichia coli ( n=663; 22.7%), Staphylococcus aureus ( n=534; 18.3%), Staphylococcus epidermidis ( n=242; 8.2%), and Pseudomonas aeruginosa ( n=176; 6.0%). Unlike Escherichia coli, which was usually acquired from the community, Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa were usually acquired in hospitals. Rates of resistance to oxacillin and its associated traits were significantly higher among hospital-acquired staphylococci as compared to those of isolates from the community. Escherichia coli was highly susceptible to extended-spectrum cephalosporins, with a very low percentage of strains producing extended-spectrum ss-lactamases (ESBLs). On the contrary, production of ESBL appeared to be an important mechanism of resistance among nosocomial isolates of Klebsiella pneumoniae. Resistance to ciprofloxacin was widespread in several members of the family Enterobacteriaceae, with rates often exceeding 10%. Moreover, with regard to ciprofloxacin, there were no significant differences between rates of resistance among Enterobacteriaceae causing hospital-acquired infections versus those causing community-acquired infections. Multidrug resistance was commonly observed in Pseudomonas aeruginosa, indicating the need for new antimicrobial agents that are more active against nonfermentative gram-negative bacteria. In conclusion, epidemiological studies of the prevalence and antimicrobial susceptibility patterns of blood isolates in northern Italy appear to provide useful information for both empirical treatment of suspected infections and better management of patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12525919     DOI: 10.1007/s10096-002-0837-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

Review 1.  Blood cultures: clinical aspects and controversies.

Authors:  J M Mylotte; A Tayara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

Review 2.  Extended-spectrum beta-lactamases: how big is the problem?

Authors:  J J Rahal
Journal:  Clin Microbiol Infect       Date:  2000-08       Impact factor: 8.067

Review 3.  Update on detection of bacteremia and fungemia.

Authors:  L G Reimer; M L Wilson; M P Weinstein
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

4.  A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome.

Authors:  M Garrouste-Orgeas; S Chevret; J L Mainardi; J F Timsit; B Misset; J Carlet
Journal:  J Hosp Infect       Date:  2000-03       Impact factor: 3.926

5.  Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase.

Authors:  F Luzzaro; E Mantengoli; M Perilli; G Lombardi; V Orlandi; A Orsatti; G Amicosante; G M Rossolini; A Toniolo
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

6.  Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns.

Authors:  V Jarlier; M H Nicolas; G Fournier; A Philippon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit.

Authors:  B Digiovine; C Chenoweth; C Watts; M Higgins
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

Review 8.  Nosocomial bloodstream infections: organisms, risk factors, and implications.

Authors:  A W Karchmer
Journal:  Clin Infect Dis       Date:  2000-09       Impact factor: 9.079

9.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

Authors:  C Brun-Buisson; F Doyon; J Carlet
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

10.  Multidrug-resistant Pseudomonas aeruginosa producing PER-1 extended-spectrum serine-beta-lactamase and VIM-2 metallo-beta-lactamase.

Authors:  J D Docquier; F Luzzaro; G Amicosante; A Toniolo; G M Rossolini
Journal:  Emerg Infect Dis       Date:  2001 Sep-Oct       Impact factor: 6.883

View more
  15 in total

1.  Frequency and antimicrobial resistance of gram-positive bacterial pathogens from bloodstream infections in the Czech Republic.

Authors:  P Cermák; M Kolár; T Látal; B Heinigeová; N Bartoníková
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

2.  Effect of Clinically Meaningful Antibiotic Concentrations on Recovery of Escherichia coli and Klebsiella pneumoniae Isolates from Anaerobic Blood Culture Bottles with and without Antibiotic Binding Resins.

Authors:  Iris H Chen; David P Nicolau; Joseph L Kuti
Journal:  J Clin Microbiol       Date:  2019-11-22       Impact factor: 5.948

3.  Proteus mirabilis bloodstream infections: risk factors and treatment outcome related to the expression of extended-spectrum beta-lactamases.

Authors:  Andrea Endimiani; Francesco Luzzaro; Gioconda Brigante; Mariagrazia Perilli; Gianluigi Lombardi; Gianfranco Amicosante; Gian Maria Rossolini; Antonio Toniolo
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.

Authors:  Lorenzo Drago; Lucia Nicola; Roberto Mattina; Elena De Vecchi
Journal:  BMC Microbiol       Date:  2010-04-21       Impact factor: 3.605

5.  Gram-positive pathogenic bacteria induce a common early response in human monocytes.

Authors:  Svetlin Tchatalbachev; Rohit Ghai; Hamid Hossain; Trinad Chakraborty
Journal:  BMC Microbiol       Date:  2010-11-02       Impact factor: 3.605

6.  Detection of bacterial and yeast species with the Bactec 9120 automated system with routine use of aerobic, anaerobic, and fungal media.

Authors:  Alfredo Chiarini; Angelo Palmeri; Teresa Amato; Rita Immordino; Salvatore Distefano; Anna Giammanco
Journal:  J Clin Microbiol       Date:  2008-10-15       Impact factor: 5.948

Review 7.  Role of newer and re-emerging older agents in the treatment of infections caused by carbapenem-resistant Enterobacteriaceae.

Authors:  Joshua T Thaden; Jason M Pogue; Keith S Kaye
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

8.  Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols.

Authors:  Manju Panghal; Vivek Kaushal; Sangeeta Kadayan; Jaya Parkash Yadav
Journal:  BMC Oral Health       Date:  2012-07-20       Impact factor: 2.757

9.  Resistant patterns of bacteria isolated from bloodstream infections at a university hospital in Delhi.

Authors:  M S Alam; P K Pillai; Prem Kapur; K K Pillai
Journal:  J Pharm Bioallied Sci       Date:  2011-10

10.  Hospital-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) in Italy.

Authors:  Floriana Campanile; Dafne Bongiorno; Sonia Borbone; Stefania Stefani
Journal:  Ann Clin Microbiol Antimicrob       Date:  2009-06-24       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.